Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.
复制标题
DOI:
10.1038/ng.1053
复制
发表时间:
2012-01-29
期刊:
影响因子:
30.8
通讯作者:
Froguel, Philippe
中科院分区:
文献类型:
--
作者:
Bonnefond, Amelie;Clement, Nathalie;Fawcett, Katherine;Yengo, Loic;Vaillant, Emmanuel;Guillaume, Jean-Luc;Dechaume, Aurelie;Payne, Felicity;Roussel, Ronan;Czernichow, Sebastien;Hercberg, Serge;Hadjadj, Samy;Balkau, Beverley;Marre, Michel;Lantieri, Olivier;Langenberg, Claudia;Bouatia-Naji, Nabila;Charpentier, Guillaume;Vaxillaire, Martine;Rocheleau, Ghislain;Wareham, Nicholas J.;Sladek, Robert;McCarthy, Mark I.;Dina, Christian;Barroso, Ines;Jockers, Ralf;Froguel, Philippe
Genome-wide association studies revealed that common non-coding variants in MTNR1B (encoding melatonin receptor 1B, also known as MT2) increase type 2 diabetes (T2D) risk. Although the strongest association signal was highly significant (P<10−20), its contribution to T2D risk was modest (odds ratio, OR~1.10-1.15). We performed large-scale exon resequencing in 7,632 Europeans including 2,186 T2D patients and identified 40 non-synonymous variants, including 36 very rare variants (minor allele frequency, MAF<0.1%) associated with T2D (OR=3.31[1.78;6.18]95%); P=1.64×10−4. A four-tier functional investigation of all 40 mutants revealed that 14 were non-functional and rare (MAF<1%); four were very rare with complete loss of melatonin binding and signaling capabilities. Among the very rare variants, the partial or total loss-of-function variants, but not the neutral ones, contributed to T2D (OR=5.67[2.17;14.82]95%; P=4.09×10−4). Genotyping the four complete loss-of-function variants in 11,854 additional individuals revealed their association with T2D risk (Ncases=8,153/Ncontrols=10,100; OR=3.88[1.49;10.07]95%; P=5.37×10−3). This study establishes a firm functional link between MTNR1B and T2D risk.
登录
查看更多内容
影响因子:
4.5
作者:
Liu DJ;Leal SM
通讯作者:
Leal SM
影响因子:
16.2
作者:
Hadjadj S;Fumeron F;Roussel R;Saulnier PJ;Gallois Y;Ankotche A;Travert F;Abi Khalil C;Miot A;Alhenc-Gelas F;Lievre M;Marre M;DIABHYCAR Study Group;DIAB2NEPHROGENE Study Group;SURDIAGENE Study Group
通讯作者:
SURDIAGENE Study Group
影响因子:
30.8
作者:
通讯作者:
--
DOI:
10.1126/science.1195027
发表时间:
2010-12-03
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Bass J;Takahashi JS
通讯作者:
Takahashi JS
影响因子:
30.8
作者:
Prokopenko I;Langenberg C;Florez JC;Saxena R;Soranzo N;Thorleifsson G;Loos RJ;Manning AK;Jackson AU;Aulchenko Y;Potter SC;Erdos MR;Sanna S;Hottenga JJ;Wheeler E;Kaakinen M;Lyssenko V;Chen WM;Ahmadi K;Beckmann JS;Bergman RN;Bochud M;Bonnycastle LL;Buchanan TA;Cao A;Cervino A;Coin L;Collins FS;Crisponi L;de Geus EJ;Dehghan A;Deloukas P;Doney AS;Elliott P;Freimer N;Gateva V;Herder C;Hofman A;Hughes TE;Hunt S;Illig T;Inouye M;Isomaa B;Johnson T;Kong A;Krestyaninova M;Kuusisto J;Laakso M;Lim N;Lindblad U;Lindgren CM;McCann OT;Mohlke KL;Morris AD;Naitza S;Orrù M;Palmer CN;Pouta A;Randall J;Rathmann W;Saramies J;Scheet P;Scott LJ;Scuteri A;Sharp S;Sijbrands E;Smit JH;Song K;Steinthorsdottir V;Stringham HM;Tuomi T;Tuomilehto J;Uitterlinden AG;Voight BF;Waterworth D;Wichmann HE;Willemsen G;Witteman JC;Yuan X;Zhao JH;Zeggini E;Schlessinger D;Sandhu M;Boomsma DI;Uda M;Spector TD;Penninx BW;Altshuler D;Vollenweider P;Jarvelin MR;Lakatta E;Waeber G;Fox CS;Peltonen L;Groop LC;Mooser V;Cupples LA;Thorsteinsdottir U;Boehnke M;Barroso I;Van Duijn C;Dupuis J;Watanabe RM;Stefansson K;McCarthy MI;Wareham NJ;Meigs JB;Abecasis GR
通讯作者:
Abecasis GR